PREDICTORS OF OCCUPATIONAL STATUS SIX MONTHS AFTER HOSPITALIZATION IN PERSONS WITH A RECENT ONSET OF PSYCHOSIS
SELECTED INFECTIOUS AGENTS AND RISK OF SCHIZOPHRENIA AMONG U.S. MILITARY PERSONNEL
COMPREHENSIVE EVALUATION OF POSITIONAL CANDIDATES IN THE IL-18 PATHWAY REVEALS SUGGESTIVE ASSOCIATIONS ITH SCHIZOPHRENIA AND HERPES VIRUS SEROPOSITIVITY
MATERNAL THYROID AUTOANTIBODIES DURING THE THIRD TRIMESTER AND HEARING DEFICITS IN CHILDREN: AN EPIDEMIOLOGIC ASSESSMENT
RESULTS FROM A HYPOTHESIS GENERTING CASE-CONTROL STUDY: HERPES FAMILY VIRUSES AND SCHIZOPHRENIA AMONG MILITARY PERSONNEL
ARE SOME CASES OF PSYCHOSIS CAUSED BY MICROBIAL AGENTS? A REVIEW OF THE EVIDENCE
DECREASED NEUROTROPIC RESPONSE TO BIRTH HYPOXIA IN THE ETIOLOGY OF SCHIZOPHRENIA
ASSOCIATION BETWEEN COGNITIVE FUNCTIONING, EXPOSURE TOHERPES SIMPLEX VIRUS TYPE 1 AND THE COMPT VAL158MET GENETIC POLYMORPHISM IN ADULTS WITHOUT A PSYCHIATRIC DISORDER
POLYMORPHISMS IN HUMAN ENDOGENOUS RETROVIRUS K-18 AND RISK OF TYPE 2 DIABETES IN INDIVIDUALS WITH SCHIZOPHRENIA
POLYMORPHISMS IN MICB ARE ASSOCATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOHRENIA RISK
DNA METHYLATION SIGNTURES WITHIN HTE HUMAN BRAIN
MATERNAL EXPOSURE TO HERPES SIMPLEX VIRUS AND RISK OF PSYCHOSIS AMONG ADULT OFFSPRING
META-ANALYSIS OF 12 GENOMIC STUDIES IN BIPOLAR DISORDER
LACK OF RIC-3 CONGRUENCE WITH BETA2 SUBUNIT-CONTAINING NICTINIC ACETYLCHOLINE RECEPTORS IN BIPOLAR DISORDER
THE ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND OCCUPATIONAL STATUS IN PERSONS WITH A RECENT ONSET OF PSYCHOSIS
THE CATECHOL O-METHYLTRANSFERASE VAL158MET POLYMORPHISM IS NOT ASSOCIATED WITH BROAD-BASED COGNITIVE FUNCTIONING IN SCHIZOPHRENIA
ELEVATED LEVELS OF HUMAN ENDOGENOUS RETROVIRUS-W TRANSCRIPTS IN BLOOD CELLS FROM PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA
POLYMORPHISMS IN MICB ARE ASSOCIATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOPHRENIA RISK
ELEVATED LEVELS OF HUMAN ENDOGENOUS RETROVIRUS-W TRANSCRIPTS IN BLOOD CELLS FROM PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA
POLYMORPHISMS IN THE HOMEOBOX GENE OTX2 MAY BE A RISK FACTOR FOR BIPOLR DISORDER
LACK OF RIC-3 CONGRUENCE WITH BETA2 SUBUNIT-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTORS IN BIPOLAR DISORDER
EARLY INFECTIONS OF TOXOPLASMA GONDII AND THE LATER DEVELOPMENT OF SCHIZOPHRENIA
REDUCED EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS (HERV)-W GAG PROTEIN IN THE CINGULATE GYRUS AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
C-REACTIVE PROTEIN IS ASSOCIATED WITH THE SEVERITY OF COGNITIVE IMPAIRMENT BUT NOT OF PSYCHIATRIC SYMPTOMS IN INDIVIDUALS WITH SCHIZOPHRENIA
ELEVATED SERUM LEVELS OF C-REACTIVE PROTEIN ARE ASSOCIATED WITH MANIA SYMPTOMS IN OUTPATIENTS WITH BIPOLAR DISORDER
ARE EXPOSURE TO CYTOMEGALOVIRUS AND GENETIC VARIATION ON CHROMOSOME 6P JOINT RISK FACTORS FOR SCHIZOPHRENIA?
NOVEL ALPHA7 NICOTINIC RECEPTOR ISOFORMS AND DEFICIENT CHOLINERGIC TRANSCRIPTION IN SCHIZOPHRENIA
POPULATION GENETIC ESTIMATION OF THE LOSS OF GENETIC DIVERSITY DURING HORIZONTAL TRANSMISSION OF HIV-1
SEROLOGICAL DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-POSITIVE AND HIGH-RISK HIV-NEGATIVE WOMEN
SEROLOGICAL CROSS REACTIVITY BETWEEN POLYOMAVIRUS CAPSIDS
TEMPLE MONKEYS AND HEALTH IMPLICATIONS OF COMMENSALISM, KATHMANDU, NEPAL
PHYLOGENOMICS AND MOLECULAR EVOLUTION OF POLYOMAVIRUSES
PREDIAGNOSTIC CIRCULATING ANTIBODIES TO JC AND BK HUMAN POLYOMAVIRUSES AND RISK OF NON-HODGKIN LYMPHOMA
COMPARING PHYLOGENETIC CODIVERGENCE BETWEEN POLYOMAVIRUSES AND THEIR HOSTS
TOXOPLASMA GONDII AS A RISK FACTOR FOR EARLY ON-SET SCHIZOPHRENIA: ANALYSIS OF FILTER PAPER BLOOD SAMPLES OBTAINED AT BIRTH
CELLULAR IMMUNE RESPONSES TO HPV-18, -31, AND -53 IN HEALTHY VOLUNTEERS IMMUNIZED WITH RECOMBINANT HPV-16 L1 VIRUS-LIKE PARTICLES
PREVALENCE OF SERUM ANTIBODIES TO HUMAN PAPILLOMA VIRUS IN PATIENTS WITH GENITAL ULCER DISEASE IN AN URBAN POPULATION OF TANZANIA
TRANSACTIVATION OF ELEMENTS IN THE HUMAN ENDOGENOUS RETROVIRUS W FAMILY BY VIRAL INFECTION
EVOLUTION OF THE HUMAN IMMUNODEFICIENCY VIRUS ENVELPE GENE IS DOMINATED BY PURIFYING SELECTION
IMMUNOGLOBULIN G, A, AND M RESPONSES TO BK VIRUS IN RENAL TRANSPLANTATION
DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS
VACCINATION OF HEALTHY VOLUNTEERS WITH HUMAN PAPILLOMAVIRUS TYPE 16 L2E7E6 FUSION PROTEIN INDUCES SERUM ANTIBODY THAT NEUTRALIZES ACROSS PAPILLOMAVIRUS SPECIES
TEMPORAL TRENDS IN GONOCOCCAL POPULATION GENETICS IN A HIGH PREVALENCE URBAN COMMUNITY
CHANGES IN REGION- AND CELL TYPE-SPECIFIC EXPRESSION PATTERNS OF NEUTRAL AMINO ACID TRANSPORTER 1 (ASCT-1) IN THE ANTERIOR CINGULATE CORTEX AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION
SEROPREVALENCE OF HUMAN PAPILLOMAVIRUS TYPES 16 AND 18 IN THE GENERAL POPULATION IN THE GENERAL POPULATION IN TAIWAN: IMPLICATION FOR OPTIMAL AGE OF HUMAN PAPILLOMAVIRUS VACCINATION
INFECTIOUS AGENTS AND GENE--ENVIRONMENTAL INTERACTIONS IN THE ETIOPATHOGENESIS OF SCHIZOPHRENIA
UPREGULATION OF THE INITIATING STEP OF THE KYNURENINE PATHWAY IN POSTMORTEM ANTERIOR CINGULATE CORTEX FROM INDIVIDUALS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
THE NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL INTRAEPITHELIAL NEOPLASMIA AMONG YOUNG WOMEN IN GHE GUANACASTE COHORT SHORTLY AFTER INITIATION OF SEXUAL LIFE
IN VITRO INHIBITION OF TOXOPLASMA GONDII BY FOUR NEW DERIVATIVES OF ARTEMISININ
ALTERED TRANSCRIPTIONAL ACTIVITY OF HUMAN ENDOGENOUS RETROVIRUSES IN NEUROEPITHELIAL CELLS AFTER INFECTION WITH TOXOPLASMA GONDII
BRAIN MORPHOLOGICAL CHANGES ASSOCIATED WITH EXPOSURE TO HSV1 IN FIRST-EPISODE SCHIZOPHRENIA
TOXOPLASMA GONDII AS A RISK FACTOR FOR EARLY-ONSET SCHIZOPHRENIA: ANALYSIS OF FILTER PAPER BLOOD SAMPLES OBTAINED AT BIRTH
ASSOCIATION STUDY OF IL10, IL1BETA, AND IL1RN AND SCHIZOPHRENIA USING TAG SNPs FROM A COMPREHENSIVE DATABASE: SUGGESTIVE ASSOCIATION WITH RS16944 AT IL1BETA
THE LYMPHOTOXIN CYS13ARG POLYMORPHISM AND COGNITIVE FUNCTIONING IN INDIVIDUALS WITH SCHIZOPHRENIA
DISC1-NDEL1/NUDEL PROTEIN INTERACTION, AN ESSENTIAL COMPONENT FOR NEURITE OUTGROWTH, IS MODULATED BY GENETIC VARIATIONS OF DISC1
CYTOMEGALOVIRUSES AND SCHIZOPHRENIA
NEUROPSYCHOLOGICAL FUNCTION IN BIPOLAR DISORDER AND SCHIZPHRENIA
ANTIBODIES TO TOXOPLASMA GONDII IN PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS
REDUCED EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS (HERV)-W GAG PROTEIN IN THE CINGULATE GYRUS AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
HSV1 EXPOSURE AFFECTS PREFRONTAL CORTICAL STRUCTURE IN SCHIZOPHRENIA PATIENTS
MITOCHONDRIAL DYSFUNCTION IN SCHIZOPHRENIA: EVIDENCE FOR COMPROMISED BRAIN METALOLISM AND OXIDATIVE STRESS
VIRUSES AND SCHIZOPHRENIA; A FOCUS ON HERPES SIMPLEX VIRUS
COGNITIVE FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDER: COMPARISON OF PERFORMANCE ON THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS
AUTISM AND HAD CIRCUMFERENCE IN THE FIRST YEAR OF LIFE
A COMPREHENSIVE GENETIC ASSOCIATION AND FUNCTIONAL STUDY OF TNF IN SCHIZOPHRENIA RISK
DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS
MUMPS VIRUS-SPECIFIC ANTIBODY TITERS FROM PRE-VACCINE ERA SERA: COMPARISON OF THE PLAQUE REDUCTION NEUTRALIZATION ASSAY AND ENZYME IMMUNOASSAYS
EVALUATING RNA STATUS FOR RT-PCR IN EXTRACTS OF POSTMORTEM HUMAN BRAIN TISSUE
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS WITH RECENT ONSET SCHIZOPHRENIA
ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND EMPLOYMENT STATUS OF PERSONS WITH BIPOLAR DISORDER
ASSOCIATION OF SERUM ANTIBODIES TO HERPES SIMPLEX VIRUS 1 WITH COGNITIVE DEFICITS IN INDIVIDUALS WITH SCHIZOPHRENIA
DRUGS USED IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER INHIBIT THE REPLICATION OF TOXOPLASMA GONDII
EPIGENETIC STUDIES OF GENOMIC RETROELEMENTS IN MAJOR PSYCHOSIS
EXPRESSION OF KYNURENINE PATHWAY ENZYME TRYPTOPHAN 2
HERPESVIRUSES AND TOXOPLASMA GONDII IN ORBITAL FRONTAL CORTEX OF PSYCHIATRIC PATIENTS
INFECTION WITH HERPES SIMPLEX VIRUS TYPW 1 IS ASSOCIATED WITH COGNITIVE DEFICITS IN BIPOLAR DISORDER
LOW MATERNAL VITAMIN D AS A RISK FACTOR FOR SCHIZOPHRENIA
NO DETECTION OF PARVOVIRUS B19 OR HERPESVIRUS DNA IN GIANT CELL ARTERITIS
OLIGODENDROCYTE DYSFUNCTION IN SCHIZOPHRENIA AND BIPOLAR DISORDER
PSYCHOPATHOLOGY IN FIRST-EPISODE SCHIZOPHRENIA AND ANTIBODIES TO TOXOPLASMA GONDII
TOXOPLASMA GONDII AND SCHIZOPHRENIA
|
